FindTrial
Sign In

A cross-sectional study to evaluate the usefulness of non-invasive hepatic fibrosis marker including Mac-2 binding protein (M2BP) and asialo a1-acid glycoprotein (AsAGP) and insulin resistance marker as a diagnostic indicator of liver fibrosis in the ultrasound-diagnosed fatty liver patients.

A cross-sectional study to evaluate the usefulness of non-invasive hepatic fibrosis marker including Mac-2 binding protein (M2BP) and asialo a1-acid glycoprotein (AsAGP) and insulin resistance marker as a diagnostic indicator of liver fibrosis in the ultrasound-diagnosed fatty liver patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0004462
Enrollment
2432
Registered
2019-11-22
Start date
2019-03-05
Completion date
Unknown
Last updated
2019-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hanyang University Seoul Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: We will use medical records from March 1, 2019 to May 31, 2019 for those who performed health check-ups including abdominal sonography at Hanyang University Medical Center.

Exclusion criteria

Exclusion criteria: 1) Foreigner 2) Missing data for skeletal muscle, sonography or alcohol consumption 3) Viral hepatitis positive or chronic liver disease 4) Alcohol consumption (>210 g for men and >140 g for women 5) Person who take a medication causing fatty liver such as steoid 6) No remnant blood sample

Design outcomes

Primary

MeasureTime frame
Mean value of target variables such as AsAGP, M2BP, Fib-4, NFS—

Secondary

MeasureTime frame
Mean analysis of target variables accoding to non alcoholic fatty liver disease—

Countries

Korea, Republic of

Contacts

Public ContactPARK YUL

Hanyang University

bliss153@hanmail.net+82-2-2290-8738

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026